ExpreS2ion will participate in key industry and investor events
Hørsholm, Denmark, September 20, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate and hold presentations at key industry and investor events in the coming month. These include PIVAC-22, a forum covering the most recent advances in cancer immunotherapy (September 26-28), and Aktiedagen Lund (September 26).By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS[2] technology platform and its exciting development pipeline, including the novel ES2B-C001 HER2-cVLP breast cancer